Characterization of new simian foamy viruses from African nonhuman primates

Virology

Volumn 237, Issue 2, 1997, Pages 349-359

  Broussard, Suzanne R ^a   Comuzzie, Anthony G ^a   Leighton, Karen L ^a   Leland, M Michelle ^a   Whitehead, Evelyn M ^a   Allan, Jonathan S ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

African green monkey; Baboon; Hamlyn's guenon; Patas; Phylogeny; SFV; Spumavirus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CERCOPITHECIDAE; CONTROLLED STUDY; EVOLUTION; HUMAN; HUMAN CELL; MONKEY; NONHUMAN; PREVALENCE; PRIMATE; PRIORITY JOURNAL; SPUMA VIRUS; VIRUS CHARACTERIZATION;

ANIMALIA; CERCOPITHECIDAE; CERCOPITHECUS AETHIOPS; ERYTHROCEBUS PATAS; HUMAN SPUMARETROVIRUS; LENS CULINARIS; PAPIO; PAPIO HAMADRYAS; PRIMATES; RABBIT FIBROMA VIRUS; SIMIAE; SIMIAN FOAMY VIRUS; SPUMAVIRUS;

EID: 0030664073     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8797     Document Type: Article

References (40)

1. Aguzzi A. The foamy virus family: Molecular biology, epidemiology, and neuropathology. Biochim. Biophys. Acta. 1155:1993;1-24.
2. Aguzzi A., Bothe K., Anhauser I., Horak I., Rethwilm A., Wagner E. F. Expression of human foamy virus is differentially regulated during development in transgenic mice. New Biol. 4:1992a;225-237.
3. Aguzzi A., Bothe K., Wagner E. F., Rethwilm A., Horak I. Human foamy virus: An underestimated neuropathogen? Brain Pathol. 2:1992b;61-69.
4. Allan J. S., Strauss J., Buck D. W. Enhancement of SIV infection with soluble receptor molecules. Science. 247:1990;1084-1088.
5. Allan J. S., Short M., Taylor M. E., Su S., Hirsch V. M., Johnson P. R., Shaw G. M., Hahn B. H. Species-specific diversity among simian immunodeficiency viruses from African green monkeys. J. Virol. 65:1991;2816-2828.
6. Bieniasz P. D., Rethwilm A., Pitman R., Daniel M. D., Chrystie I., McClure M. O. A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology. 207:1995;217-228.
7. Bothe K. A., Aguzzi A., Lassmann A., Rethwilm A., Horak I. Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science. 253:1991;555-557.
8. Brown P., Nemo G., Gajdusek D. C. Human foamy virus: Further characterization, seroepidemiology, and relationship to chimpanzee foamy viruses. J. Infect. Dis. 137:1978;421-427.
9. Disotell T. R. The phylogeny of Old World monkeys. Evol. Anthropol. 5:1996;18-24.
10. Franchini G., Reitz M. S. Jr. Tenth anniversary perspective on AIDS. Phylogenesis and genetic complexity of the nonhuman primate retroviridae. AIDS Res. Hum. Retroviruses. 10:1994;1047-1060.
11. Giron M.-L., Rozain F., Debons-Guillemin M.-C., Canivet M., Peries J., Emanoil-Ravier R. Human foamy virus polypeptides: Identification ofenvbel. J. Virol. 67:1993;3596-3600.
12. Hahn H., Baunach G., Brautigam S., Mergia A., Neumann-Haefelin D., Daniel M. D., McClure M. O., Rethwilm A. Reactivity of primate sera to foamy virus Gag and Bet proteins. J. Gen. Virol. 75:1994;2635-2644.
13. He F., Sun J. D., Garrett E. D., Cullen B. R. Functional organization of the Bel-1trans. J. Virol. 67:1993;1896-1904.
14. Herchenroder O., Renne R., Loncar D., Cobb E. K., Murthy K. K., Schneider J., Mergia A., Luciw P. A. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): High homology to human foamy virus (HFV). Virology. 201:1994;187-199.
15. Herchenroder O., Turek R., Neumann-Haefelin D., Rethwilm A., Schneider J. Infectious proviral clones of chimpanzee foamy virus (SFVcpz) generated by long PCR reveal close functional relatedness to human foamy virus. Virology. 214:1995;685-689.
16. Hooks J. J., Gibbs C. J. Jr. The foamy viruses. Bacteriol. Rev. 39:1975;169-185.
17. Jin M. J., Rogers J., Phillips-Conroy J. E., Allan J. S., Desrosiers R. C., Shaw G. M., Sharp P. M., Hahn B. H. Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: Evidence for cross-species transmission in the wild. J. Virol. 68:1994;8454-8460.
18. Konvalinka J., Lochelt M., Zentgraf H., Flugel R. M., Krausslich H.-G. Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J. Virol. 69:1995;7264-7268.
19. Lochelt M., Flugel R. M. The human foamy viruspol. J. Virol. 70:1996;1033-1040.
20. Lycke J., Svennerholm B., Svenningsson A., Muranyi W., Flugel R. M., Andersen O. Human spumaretrovirus antibody reactivity in multiple sclerosis. J. Neurol. 241:1994;204-209.
21. Mahnke C., Kashaiya P., Rossler J., Bannert H., Levin A., Blattner W. A., Dietrich M., Luande J., Lochelt M., Friedman-Kien A. E., Komaroff A. L., Loh P. C., Westarp M.-S., Flogel R. M. Human spumavirus antibodies in sera from African patients. Arch. Virol. 123:1992;243-253.
22. McClure M. O., Bieniasz P. D., Schulz T. F., Chrystie I. L., Simpson G., Aguzzi A., Hoad J. G., Cunningham A., Kirkwood J., Weiss R. A. Isolation of a new foamy retrovirus from orangutans. J. Virol. 68:1994;7124-7130.
23. Mergia A., Pratt-Lowe E., Shaw K. E. S., Renshaw-Gegg L. W., Luciw P. A. cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1. J. Virol. 66:1992;251-257.
24. Mergia A., Renshaw-Gegg L. W., Stout M. W., Renne R., Herchenroeder O. Functional domains of the simian foamy virus type 1 transcriptional transactivator (Taf). J. Virol. 67:1993;4598-4604.
25. Mone J., Whitehead E., Leland M., Hubbard G., Allan J. S. Simian T-cell leukemia virus type I infection in captive baboons. AIDS Res. Hum. Retroviruses. 8:1992;1653-1661.
26. Nemo G. J., Brown P. W., Gibbs C. J. Jr., Gajdusek D. C. Antigenic relationship of human foamy virus to the simian foamy viruses. Infect. Immunol. 20:1978;69-72.
27. Netzer K.-O., Schliephake A., Maurer B., Watanabe R., Aguzzi A., Rethwilm A. Identification of pol-related gene products of human foamy virus. Virology. 192:1993;336-338.
28. Neumann-Haefelin D., Fleps U., Renne R., Schweizer M. Foamy viruses. Intervirology. 35:1993;196-207.
29. Neumann-Haefelin D., Schweizer M. Nonhuman primate spumavirus infections among persons with occupational exposure- United States, 1996. MMWR Wkly. 46:1997;129-131.
30. Renne R., Fleps U., Luciw P. A., Neumann-Haefelin D. Transactivation of the two promoters of SFV-3 by different mechanisms. Virology. 221:1996;362-367.
31. Renne R., Mergia A., Renshaw-Gegg L. W., Neumann-Haefelin D., Luciw P. A. Regulatory elements in the long terminal repeat (LTR) of simian foamy virus type 3 (SFV-3). Virology. 192:1993;365-369.
32. Rethwilm A. Regulation of foamy virus gene expression. Curr. Topics Microbiol. Immunol. 193:1995;1-24.
33. Ruvolo M. Genetic evolution of the African guenons. A Primate Radiation, Evolutionary Biology of the African Guenons. 1988;Cambridge Univ. Press, Cambridge. p. 127-139.
34. Saib A., Canivet M., Giron M.-L., Bolgert F., Valla J., Lagaye S., Peries J., de The H. Human foamy virus infection in myasthenia gravis [letter]. Lancet. 343:1994;666.
35. Schweizer M., Turek R., Reinhardt M., Neumann-Haefelin D. Absence of foamy virus DNA in Graves' disease. AIDS Res. Hum. Retroviruses. 10:1994;601-605.
36. Schweizer M., Turek R., Hahn H., Schliephake A., Netzer K.-O., Eder G., Reinhardt M., Rethwilm A., Neumann-Haefelin D. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res. Hum. Retroviruses. 11:1995;161-170.
37. Stiles G. E., Bittle J. L., Cabasso V. J. Comparison of simian foamy virus strains including a new serological type. Nature (London). 201:1964;1350-1351.
38. Weiss R. A. Foamy viruses bubble on [news]. Nature. 380:1996;201.
39. Wick G., Grubeck-Loebenstein B., Trieb K., Kalischnig G., Aguzzi A. Human foamy virus antigens in thyroid tissue of Graves' disease patients. Int. Arch. Allergy Immunol. 99:1992;153-156.
40. Wick G., Trieb K., Aguzzi A., Recheis H., Anderl H., Grubeck-Loebenstein B. Possible role of human foamy virus in Graves' disease. Intervirology. 35:1993;101-107.